{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:56:00Z","timestamp":1793620560215,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.semnephrol.2024.151496","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:53:59Z","timestamp":1710424439000},"page":"151496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systemic Amyloidosis and Kidney Transplantation: An Update"],"prefix":"10.1016","volume":"44","author":[{"given":"Shankara K.","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semnephrol.2024.151496_bib0001","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0003","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"29","author":"Buxbaum","year":"2022","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151496_bib0004","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151496_bib0005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0006","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jaccao.2021.06.006","article-title":"ATTR amyloidosis: current and emerging management strategies: JACC: CardioOncology state-of-the-art review","volume":"3","author":"Griffin","year":"2021","journal-title":"JACC CardioOncol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0007","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.kint.2022.10.028","article-title":"Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review","volume":"103","author":"Karam","year":"2023","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151496_bib0008","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2215\/CJN.12551214","article-title":"Leukocyte cell-derived chemotaxin 2-associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics","volume":"10","author":"Nasr","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0009","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.kint.2020.06.036","article-title":"A study from the Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis","volume":"99","author":"Heybeli","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2024.151496_bib0010","doi-asserted-by":"crossref","first-page":"29096","DOI":"10.1038\/srep29096","article-title":"In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study","volume":"6","author":"Ami","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2024.151496_bib0011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","article-title":"Amyloidosis","volume":"57","author":"Pepys","year":"2006","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0012","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/13506129.2012.711391","article-title":"AA-amyloid is cleared by endogenous immunological mechanisms","volume":"19","author":"Nystr\u00f6m","year":"2012","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151496_bib0013","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/PAS.0b013e3181abdfa7","article-title":"Prevalence and origin of amyloid in kidney biopsies","volume":"33","author":"von Hutten","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151496_bib0014","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0015","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1046\/j.1523-1755.2003.00167.x","article-title":"Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro","volume":"64","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0016","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","article-title":"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies","volume":"7","author":"Coresh","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0017","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/PL00000706","article-title":"Immunoglobulin light chains, glycosaminoglycans, and amyloid","volume":"57","author":"Stevens","year":"2000","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0018","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.V98.3.714","article-title":"The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden","volume":"98","author":"Comenzo","year":"2001","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151496_bib0019","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1681\/ASN.2005040382","article-title":"Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis","volume":"16","author":"Gregorini","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"4-5","key":"10.1016\/j.semnephrol.2024.151496_bib0020","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jmb.2012.01.004","article-title":"Roles of extracellular chaperones in amyloidosis","volume":"421","author":"Wyatt","year":"2012","journal-title":"J Mol Biol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151496_bib0021","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151496_bib0022","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3324\/haematol.2009.008912","article-title":"Current treatment of AL amyloidosis","volume":"94","author":"Palladini","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0023","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2141.2007.06936.x","article-title":"Perspectives in treatment of AL amyloidosis","volume":"140","author":"Wechalekar","year":"2008","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0024","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4103\/0377-4929.142712","article-title":"Unique morphology of intratubular light chain casts in multiple myeloma: the amyloid cast nephropathy","volume":"57","author":"Sharma","year":"2014","journal-title":"Indian J Pathol Microbiol"},{"issue":"23","key":"10.1016\/j.semnephrol.2024.151496_bib0025","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.2169\/internalmedicine.54.5174","article-title":"Rapid deterioration of the renal function caused by the coexistence of intratubular amyloidosis and myeloma cast nephropathy","volume":"54","author":"Kato","year":"2015","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0026","first-page":"377","article-title":"AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product","volume":"137","author":"Westermark","year":"1990","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0027","first-page":"137","article-title":"Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria","volume":"19","author":"Falck","year":"1983","journal-title":"Clin Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151496_bib0028","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3324\/haematol.2013.102764","article-title":"Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics","volume":"99","author":"Vrana","year":"2014","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151496_bib0029","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.humpath.2007.04.013","article-title":"Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response","volume":"38","author":"Verine","year":"2007","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151496_bib0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0272-6386(96)90250-4","article-title":"Extracapillary glomerulonephritis and renal amyloidosis","volume":"28","author":"Moroni","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0031","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.kint.2016.04.003","article-title":"Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis","volume":"90","author":"Dasari","year":"2016","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0032","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ki.2011.316","article-title":"Medullary amyloidosis associated with apolipoprotein A-IV deposition","volume":"81","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0033","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000168336","article-title":"Fanconi's syndrome, kappa light-chain myeloma, non-amyloid fibrils and cytoplasmic crystals in renal tubular epithelium","volume":"11","author":"Orfila","year":"1991","journal-title":"Am J Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151496_bib0034","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/ndt\/gfp201","article-title":"Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney","volume":"24","author":"Gertz","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"23","key":"10.1016\/j.semnephrol.2024.151496_bib0035","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.semnephrol.2024.151496_bib0036","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/eurheartj\/ehx047","article-title":"Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis","volume":"38","author":"Quarta","year":"2017","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151496_bib0037","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/07853890.2017.1304649","article-title":"Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition","volume":"49","author":"Muchtar","year":"2017","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0038","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.kint.2019.05.027","article-title":"The sensitivity and specificity of the routine kidney biopsy immunofluorescence panel are inferior to diagnosing renal immunoglobulin-derived amyloidosis by mass spectrometry","volume":"96","author":"Gonzalez Suarez","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2024.151496_bib0039","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.talanta.2017.12.072","article-title":"A chemometric approach for characterization of serum transthyretin in familial amyloidotic polyneuropathy type I (FAP-I) by electrospray ionization-ion mobility mass spectrometry","volume":"181","author":"Pont","year":"2018","journal-title":"Talanta"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12350-013-9800-5","article-title":"Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques","volume":"21","author":"Aljaroudi","year":"2014","journal-title":"J Nucl Cardiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151496_bib0041","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00007890-197711000-00011","article-title":"Transplantation for renal amyloidosis","volume":"24","author":"Kennedy","year":"1977","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151496_bib0042","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00007890-198612000-00005","article-title":"Renal transplantation in 45 patients with amyloidosis","volume":"42","author":"Pasternack","year":"1986","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0043","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/TP.0000000000001930","article-title":"Patient and kidney allograft survival in recipients with end-stage renal disease from amyloidosis","volume":"102","author":"Sawinski","year":"2018","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0044","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ndt\/gfaa293","article-title":"Renal transplant outcomes in amyloidosis","volume":"36","author":"Law","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"3-4","key":"10.1016\/j.semnephrol.2024.151496_bib0046","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/10428199709059685","article-title":"Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation","volume":"27","author":"Desikan","year":"1997","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0047","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4065\/mcp.2009.0547","article-title":"Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma","volume":"85","author":"Madan","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0048","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2016-10-743997","article-title":"Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry","volume":"129","author":"Kourelis","year":"2017","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.semnephrol.2024.151496_bib0049","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0050","first-page":"81","article-title":"Chronic dialysis in patients with systemic amyloidosis: the experience in northern Italy","volume":"38","author":"Moroni","year":"1992","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0051","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000168121","article-title":"End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis","volume":"10","author":"Martinez-Vea","year":"1990","journal-title":"Am J Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151496_bib0052","doi-asserted-by":"crossref","first-page":"E458","DOI":"10.1002\/ajh.24464","article-title":"Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation","volume":"91","author":"Havasi","year":"2016","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151496_bib0053","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.2010.30.5235","article-title":"Outcome in renal Al amyloidosis after chemotherapy","volume":"29","author":"Pinney","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0054","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2215\/CJN.02470607","article-title":"Presentation and outcome of patients with systemic amyloidosis undergoing dialysis","volume":"3","author":"Boll\u00e9e","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0055","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood.V93.3.1062","article-title":"Long-term survival (10 years or more) in 30 patients with primary amyloidosis","volume":"93","author":"Kyle","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0056","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0002-9343(97)89487-9","article-title":"Treatment of 100 patients with primary amyloidosis: a randomized trial of melphalan, prednisone, and colchicine versus colchicine only","volume":"100","author":"Skinner","year":"1996","journal-title":"Am J Med"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2024.151496_bib0057","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.amjmed.2022.01.011","article-title":"Update on the contemporary treatment of light chain amyloidosis including stem cell transplantation","volume":"135","author":"Abdallah","year":"2022","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151496_bib0058","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2017-02-767467","article-title":"Patients with light-chain amyloidosis and low free light-chain burden have distinct clinical features and outcome","volume":"130","author":"Milani","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151496_bib0059","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/leu.2017.286","article-title":"Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains","volume":"32","author":"Sidana","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0061","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5414\/CN107162","article-title":"A patient with persistent renal AL amyloid deposition after clinical remission by HDM\/SCT therapy","volume":"79","author":"Okuyama","year":"2013","journal-title":"Clin Nephrol"},{"issue":"12","key":"10.1016\/j.semnephrol.2024.151496_bib0062","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1093\/ndt\/gfg436","article-title":"No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement","volume":"18","author":"Zeier","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0063","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1523-1755.2003.00813.x","article-title":"High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease","volume":"63","author":"Casserly","year":"2003","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.semnephrol.2024.151496_bib0064","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/j.1600-6143.2005.00920.x","article-title":"Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement","volume":"5","author":"Leung","year":"2005","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151496_bib0065","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfr067","article-title":"Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation","volume":"26","author":"Herrmann","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0066","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.kint.2018.09.021","article-title":"Long-term outcome of kidney transplantation in AL amyloidosis","volume":"95","author":"Angel-Korman","year":"2019","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151496_bib0067","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2010.03227.x","article-title":"Solid organ transplantation in AL amyloidosis","volume":"10","author":"Sattianayagam","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151496_bib0068","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41408-022-00714-5","article-title":"Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through the International Kidney and Monoclonal Gammopathy Research Group","volume":"12","author":"Havasi","year":"2022","journal-title":"Blood Cancer J"},{"issue":"22","key":"10.1016\/j.semnephrol.2024.151496_bib0069","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V128.22.3261.3261","article-title":"Persistence of minimal residual disease by multiparameter flow cytometry can hinder recovery of organ damage in patients with AL amyloidosis otherwise in complete response","volume":"128","author":"Palladini","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151496_bib0070","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ajh.25746","article-title":"Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis","volume":"95","author":"Sidana","year":"2020","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.semnephrol.2024.151496_bib0071","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.mayocp.2020.06.029","article-title":"Amyloid typing by mass spectrometry in clinical practice: a comprehensive review of 16,175 samples","volume":"95","author":"Dasari","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151496_bib0072","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/msj.21342","article-title":"AA amyloidosis: Mount Sinai experience, 1997-2012","volume":"79","author":"Bunker","year":"2012","journal-title":"Mt Sinai J Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151496_bib0073","doi-asserted-by":"crossref","first-page":"e13966","DOI":"10.1111\/ijcp.13966","article-title":"Infections and AA amyloidosis: an overview","volume":"75","author":"Deshayes","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.semnephrol.2024.151496_bib0074","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biochi.2014.05.007","article-title":"Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A","volume":"104","author":"Aguilera","year":"2014","journal-title":"Biochimie"},{"issue":"32","key":"10.1016\/j.semnephrol.2024.151496_bib0075","doi-asserted-by":"crossref","first-page":"E6507","DOI":"10.1073\/pnas.1707120114","article-title":"Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis","volume":"114","author":"Jayaraman","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2024.151496_bib0076","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/13506129.2017.1289917","article-title":"Prognostication of survival and progression to dialysis in AA amyloidosis","volume":"24","author":"Palladini","year":"2017","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151496_bib0077","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343398","article-title":"Renal involvement in AA amyloidosis: clinical outcomes and survival","volume":"37","author":"Yilmaz","year":"2013","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0078","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-6143.2012.04326.x","article-title":"Renal transplantation in systemic amyloidosis\u2014importance of amyloid fibril type and precursor protein abundance","volume":"13","author":"Pinney","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151496_bib0079","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archinte.1979.03630470047016","article-title":"Renal transplantation in the amyloidosis of familial Mediterranean fever. Experience in ten cases","volume":"139","author":"Jacob","year":"1979","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151496_bib0080","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10067-012-1992-6","article-title":"Renal transplantation in patients with familial Mediterranean fever","volume":"31","author":"Erdem","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0081","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0272-6386(03)00676-0","article-title":"Long-term outcome of live donor kidney transplantation for renal amyloidosis","volume":"42","author":"Sherif","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0082","doi-asserted-by":"crossref","first-page":"324","DOI":"10.6002\/ect.2018.0371","article-title":"Long-term outcomes of patients with amyloidosis following kidney transplant","volume":"21","author":"Heybeli","year":"2023","journal-title":"Exp Clin Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0083","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ki.2008.152","article-title":"Leukocyte chemotactic factor 2: a novel renal amyloid protein","volume":"74","author":"Benson","year":"2008","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0084","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/ki.2014.11","article-title":"Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis","volume":"86","author":"Larsen","year":"2014","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151496_bib0085","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2013-07-517938","article-title":"Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States","volume":"123","author":"Mereuta","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0086","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/ki.2013.558","article-title":"Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis","volume":"86","author":"Said","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151496_bib0087","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1053\/j.ajkd.2014.06.017","article-title":"Renal leukocyte chemotactic factor 2 (LECT2) amyloidosis in First Nations people in Northern British Columbia, Canada: a report of 4 cases","volume":"64","author":"Hutton","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0088","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.2016.29","article-title":"Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians","volume":"29","author":"Larsen","year":"2016","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.semnephrol.2024.151496_bib0089","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1053\/j.ajkd.2018.10.016","article-title":"LECT2 amyloidosis in kidney transplantation: a report of 5 cases","volume":"74","author":"Mejia-Vilet","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0090","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3109\/13506120308998998","article-title":"Tabulation of human transthyretin (TTR) variants, 2003","volume":"10","author":"Connors","year":"2003","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.semnephrol.2024.151496_bib0091","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2215\/CJN.08720811","article-title":"Transthyretin amyloidosis and the kidney","volume":"7","author":"Lobato","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2024.151496_bib0092","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.semnephrol.2024.151496_bib0093","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3109\/13506129.2011.574354071","article-title":"Combined liver-kidney transplantation in familial amyloidotic polyneuropathy TTR V30M: nephrological assessment","volume":"18","author":"Lobato","year":"2011","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0094","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/13506129.2013.781998","article-title":"Hereditary amyloidosis caused by R554L fibrinogen A\u03b1-chain mutation in a Spanish family and review of the literature","volume":"20","author":"Haidinger","year":"2013","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.semnephrol.2024.151496_bib0096","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ekir.2016.11.005","article-title":"Renal amyloidosis associated with 5 novel variants in the fibrinogen A alpha chain protein","volume":"2","author":"Rowczenio","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.semnephrol.2024.151496_bib0097","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2024.151496_bib0098","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/j.1600-6143.2006.01507.x","article-title":"Organ transplantation in hereditary apolipoprotein AI amyloidosis","volume":"6","author":"Gillmore","year":"2006","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.semnephrol.2024.151496_bib0099","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/MAJ.0b013e3181a4199c","article-title":"Outcome of renal transplant in hereditary gelsolin amyloidosis","volume":"337","author":"Shoja","year":"2009","journal-title":"Am J Med Sci"},{"issue":"6","key":"10.1016\/j.semnephrol.2024.151496_bib0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/07853890.2015.1075063","article-title":"Natural course of Finnish gelsolin amyloidosis","volume":"47","author":"Nikoskinen","year":"2015","journal-title":"Ann Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2024.151496_bib0101","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2796.2011.02470.x","article-title":"Hereditary lysozyme amyloidosis\u2014phenotypic heterogeneity and the role of solid organ transplantation","volume":"272","author":"Sattianayagam","year":"2012","journal-title":"J Intern Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929524000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T14:51:16Z","timestamp":1748357476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929524000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0270929524000135"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151496","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Amyloidosis and Kidney Transplantation: An Update","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2024.151496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151496"}}